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Abstract
Objective. To evaluate the clinical manifestations of hepatic encephalopathy (HE) in patients with alcohol liver cirrhosis (ALC)
in exacerbation of chronic bronchitis (CB).
Materials and methods. 100 patients with ALC class B and C according to Child-Pugh, 82.00% of men and 18.00% of
women aged (47.2±3.9) years, were examined: 48 patients without combination with CB (group I); 52 patients on the
background of CB exacerbation (group II). Clinical-laboratory and instrumental examination was performed. The West-Haven
criteria were used to assess the HE.
Results. In 54.17% of patients in group I, the I degree of HE was determined, in 35.42% - the II degree, in 10.42% - the III
degree. In patients of group II the HE of the I degree was found in 17.31%, the II degree - in 50.0%, the III degree - in 32.69%
(p<0.05). In patients with ALC and ALC in combination with CB, respectively, clinically HE was manifested by drowsiness
in the daytime and the inversion of sleep (58.33%; 75.00%), lengthening the duration of the TMT-time test (61.59±2.38
sec; 72.84±3.03 sec), mood disorders (20.83%; 28.85%), appearance of asterixis (54.17%; 76.92%), constructive apraxia
(41.67%; 55.77%).
Conclusions. 1. Exacerbation of CB in patients with ALC contributes to the increase in the degree of HE, worsening the
prognosis. 2. The relationship between the hyponatremia and the degree of HE is revealed.
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Problem statement and analysis of the
recent research
According to the WHO, worldwide chronic liver diseases in
2020 could cause more than 2.5 million deaths, predicting
about 1 million deaths from liver cirrhosis (LC). According
to the statistics, in 2015 in Ukraine [5], among all fatal cases
more than 4% were due to the diseases of the digestive system,
among which about half - were due to the decompensation
of liver cirrhosis. The main etiological factors of the LC are
hepatotropic viruses B, C, D and alcohol [12].
Hepatic insufficiency is clinically manifested by hepatic
encephalopathy, jaundice, ascites, edema of tissues, hem-
orrhagic syndrome, hyperdynamic type of circulation, pal-
mar erythema, telangiectasia, liver odor (fetor hepaticus),
endocrine changes, fever, septicemia [3, 7]. Hepatic en-
cephalopathy (HE) is the most indicant and sensitive clinical
manifestation of liver failure, which clearly reflects its positive
or negative dynamics. One of the most important prognostic
criteria, which allows assess the severity of the patients’ con-
dition with alcoholic liver cirrhosis (ALC), is the appearance
and progression of hepatic encephalopathy (HE). According
to the latest accepted definitions by the International Organi-
zation for the Study of Hepatic Encephalopathy and Nitrogen
Exchange (IOSHENE), the emergence of disorientation or
asterixis is considered the beginning of the HE [4].
Hepatic encephalopathy (HE) - is a complex of poten-
tially reverse mental and neuromuscular disorders caused by
severe hepatic insufficiency. HE in patients with LC can de-
velop under the influence of trigger factors, which include
gastrointestinal bleeding, infections such as bacterial ascites-
peritonitis, and also infectious-associated conditions of other
organs and systems, including the respiratory tract, intake of
sedative drugs and tranquilizers, alcohol, excessive use of ani-
mal proteins, surgical intervention because of other diseases,
paracentesis with the removal of a large amount of ascitic
fluid [3].
Another independent predictor of mortality in patients
with LC is the low serum sodium concentration, but its preva-
lence and clinical significance are not fully studied. Hypona-
tremia is defined when serum sodium level is <135 mmol/l,
and in LC - is <130 mmol/l [11, 14]. It is proved that hypona-
traemia is an independent predictor of an adverse prognosis,
and often it combines with refractory ascites, spontaneous
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bacterial peritonitis, and HE [9]. A greater incidence of these
complications was observed in patients with serum sodium
level<130 mmol/l, and also significantly increased in patients
with moderate serum sodium level - up to 131-135 mmol/l
[6, 14]. In patients without LC, hyponatremia, depending on
severity, can lead to a number of symptoms, including mild
cognitive dysfunction, convulsions, coma occasionally death
[11]. Hyponatremia in the LC is a chronic process and it
allows the brain to adapt to the hypo-osmolality of the ex-
tracellular fluid. The most important factor in determining
the severity of the HE in patients with hyponatremia is the
rate of reduction of sodium in blood serum [8]. However,
hyponatraemia may trigger brain edema, which, along with
the effect of ammonia in ALC patients, can accelerate the HE
[6, 8].
The objective of the study was to evaluate the clinical
manifestations of the HE in ALC patients in the presence of
exacerbation of chronic bronchitis.
1. Materials and methods of the research
100 patients with diagnosed alcoholic cirrhosis of the liver
(ALC), 82.00% of men and 18.00% of women aged (47.2±3.9)
years, were examined: 48 patients with ALC, class B and C ac-
cording to Child-Pugh without a combination with CB (group
I); 52 ALC patients, class B and C according to Child-Pugh in
combination with CB in the phase of exacerbation (group II).
The control group consisted of 20 practically healthy persons.
Diagnosis of ALC was established according to the Adapted
clinical guideline ”Alcoholic liver disease” (2014) and the
protocols of medical care provision on the specialty ”Gas-
troenterology” (Order of the Ministry of Health of Ukraine #
271 dated 13.06.2005), ”Alcoholic Hepatitis” (Order of the
Ministry of Health of Ukraine # 826 dated 06.11. 2014).
A general clinical examination (analysis of complaints,
anamnesis of the disease, anamnesis of life, objective status),
ultrasound examination (US) of the abdominal cavity organs,
esophagogastroduodenoscopy were performed. CAGE and
AUDIT questionnaires were used to confirm the LC of the
alcoholic genesis. The severity of the LC was assessed ac-
cording to the Child-Pugh criteria (Engl. Child-Pugh, Child-
Turcotte, Child-Turcotte-Pugh, and sometimes Child-Paquet).
For the comparison of manifestations of hepatic encephalopa-
thy (HE), there was used index, which was based on: the pa-
tient’s mental status, TMT-time (”exit from the labyrinth” test),
asterixis (flapping-tremor). The criteria proposed by West-
Haven [2] were used to estimate the HE. The functional state
of the liver was evaluated according to the activity of aspartate
aminotransferase (AsAT), alanine aminotransferase (ALAT),
gammaglutamyltranspeptidase (GGTP), alkaline phosphatase
(AP), content of total bilirubin and protein. Serum creatinine,
urea, sodium, and INR were determined.
The exclusion criteria were liver cirrhosis of the viral,
toxic genesis; chronic hepatitis, steatosis of various geneses;
metabolic liver diseases; decompensated somatic pathology,
oncological diseases, bronchial asthma; chronic obstructive
pulmonary disease; lack of individual consent of the patient
to perform the study.
The statistical processing of the received results was car-
ried out using the software - Microsoft Excel spreadsheet and
Statistica v. 10.0 StatSoft, USA. The assessment of the proba-
bility of differences in the mean values was performed using
the Student’s paired t-criterion.
2. Results of the research and their
discussion
Among the examined patients, in the presence of CB exacer-
bation, ALC class C was more often diagnosed according to
Child-Pugh - in 36.53% of cases in group II compared with
14.58% of cases in group I (Table 1).
Table 1. Division of patients with alcoholic liver cirrhosis
according to the Child-Pugh criteria
Class of LC
Patients
Group I, n=48 Group II, n=52
n % n %
Class B 41 85.42 33 63.47
Class C 7 14.58 19 36.53*
Totally 48 100.00 52 100.00
Note. * – the reliability of the difference in the indicators in the
groups I and II, p<0.05.
In 54.17% of patients with ALC there was established the
first degree of the hepatic ecephalopathy (HE) according to
West-Haven, in 35.42% - the second degree of the HE and in
10.42% - the third degree of the HE. ALC with an exacerbation
of CB in patients of the group II the third degree of the HE
1.9-fold (p<0.05) was found more often; that indicated the
aggravating effect of the exacerbation of CB on the course of
ALC with the development of complication in the form of the
HE (Table 2).
In patients with ALC and ALC in combination with CB
clinically HE was manifested as sleep disturbance, daytime
sleepiness and sleep inversion (58.33%; 75.00% respectively),
decreased mnemonic functions, ability to logical thinking and
attention concentration (52.08%; 73.08%), including length-
ening the duration of the TMT-time test (61.59±2.38 sec;
72.84±3.03 sec), mood impairment due to depression, aggres-
siveness, irritability (20.83%; 28.85%), euphoria, inadequate
assessment of their own condition (43.75%; 57.69%), aster-
ixis in the form of slapping movements (54.17%; 76.92%),
constructive apraxia (41.67%; 55.77% respectively).
In patients with ALC, exacerbation of CB was accompa-
nied by an increase of liver failure in 86.54% of cases with
a deterioration of the indicators of the functional state of the
liver with an increase in the content of bilirubin at 59.53%
(p<0.05), the activity of AsAT, ALAT and GGTP at 72.41%,
194.64%, 47.45% respectively (p<0.05), (Table 3).
Patients of the group I have significantly increased serum
creatinine and urea levels at 76.34% and 26.85% (p<0.05)
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Table 2. Characteristics of manifestations of hepatic encephalopathy in patients with alcoholic liver cirrhosis depending on the
presence of chronic bronchitis in the degree of exacerbation
Manifestations of hepatic encephalopathy Group I, n=48 Group II, n=52
TMT-time (sec) 65.28±2.33 72.84±4.71
Abs. % Abs. %
Asterixis (flapping-tremor) 41 85.42 47 90.38
Degree of hepatic encephalopathy according to West-Haven criteria:
- degree I 26 54.17 9 17.31•
- degree II 17 35.42 26 50.0
- degree III 5 10.42 17 32.69•
Note. • – the reliability of the difference in the indicators in group II compared to the group I, p<0.05.
Table 3. Laboratory indices in patients with alcoholic liver cirrhosis against the background of exacerbation of chronic
bronchitis
Indeces Healthy, n=20 Group I, n=48 Group II, n=52
Bilirubin total, mcmol/l 15.03±0.47 55.13±3.25* 87.95±1.95*•
AsAT, mmol/hour*l 0.31±0.01 0.87±0.05* 1.50±0.09*•
ALAT, mmol/hour*l 0.29±0.01 0.56±0.04* 1.65±0.08*•
GGTP, mmol/hour*l 4.99±0.023 19.07±0.64* 28.12±0.92*•
Urea, mmol/l 4.99±0.03 6.33±0.41* 8.98±0.53*•
Creatinine, mcmol/l 75.28±3.17 132.75±51.6* 182.79±8.06*•
Total protein, g/l 78.18±2.26 64.28±2.43* 57.22±2.64*•
Albumin, g/l 41.73±2.23 33.27±1.94* 27.34±2.05*•
Na blood serum, mmol/l 146.28±3.02 138.86±3.35 131.47±4.05
INR 1.19±0.06 1.35±0.09* 2.39±0.015*•
Note.
* – the reliability of the differences in the indicators in groups I and II compared with the healthy ones, p<0.05;
• – the reliability of the difference in the indicators in group II compared to the group I, p<0.05.
compared with the healthy persons. In patients of the group
II the disorders of nitrogen exchange tended to have a more
pronounced tendency, and respectively, were accompanied
by the increased levels of creatinine and urea compared with
the control group at 142.81% and at 79.96% respectively
(p<0.05) and compared to patients in group I - at 37.69% and
at 41.86% respectively (p<0.05). Direct correlations between
the HE degree and the content of bilirubin in the blood and
the INR index were found (r = + 0.63; r = + 0.45; respectively,
p<0.05).
The proportional increase in the concentration of serum
creatinine and diuresis control over many years and up to this
day remains important indicators of decreased renal function
in the LC. However, in patients with LC, due to the decrease
in the mass of muscular tissue, and therefore the synthesis of
creatinine, even a sharp decrease in glomerular filtration may
be accompanied by a normal or slightly elevated creatinine
level. Instead, hyponatremia is a more accurate marker for
predicting the probable complications of the LC [10]. In
patients of groups I and II, the mean values of serum sodium
at 5.07% (p>0.05) and at 10.12% (p<0.05) were lower than
in the control group. The serum sodium level >135 mmol/l,
≤135 mmol/l, ≤130 mmol/l was 57.92%, 36.67%, and 5.41%
respectively in group I - against 26.92%, 43.85%, and 29.23%
respectively in group II. The reverse correlations between the
HE degree and the serum sodium level (r = -0.65, p<0.05)
were found.
According to the results of the study, it was found that a
more unfavorable prognosis for the ALC course according
to the MELD index was in patients of the group II in the
presence of CB exacerbation. In particular, the MELD index
for patients of the group I was 12.52 ± 0.61 points, while
the second group was 16.34 ± 0.75 points. The correlations
between the MELD index and the HE degree, the INR index (r
= + 0.70, + 0.56, p<0.05) and the hyponatremia by the serum
sodium level (r = -0.52, p<0.05) were determined.
3. Conclusions
1. Exacerbation of CB in patients with ALC contributes
to the increase of the HE degree, which is accompanied
by a deterioration of the prognosis by the MELD index
and requires timely adequate therapy.
2. Hyponatremia is observed more often in patients with
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ALC with an exacerbation of CB; an inverse correlation
between serum sodium level and HE degree was found.
4. Prospects for further research
Prospects of further research – it is the study of pathogenetic
links in the development of hepatic encephalopathy in patients
with ALC in exacerbation of CB for the choice of effective
integrated therapy.
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